Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049) 3-Year EBITDA Growth Rate : 6.50% (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Jilin Province Huinan Changlong Bio-pharmacy Co 3-Year EBITDA Growth Rate?

Jilin Province Huinan Changlong Bio-pharmacy Co's EBITDA per Share for the three months ended in Dec. 2023 was HK$0.07.

During the past 12 months, Jilin Province Huinan Changlong Bio-pharmacy Co's average EBITDA Per Share Growth Rate was -4.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 6.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 2.90% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 4.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Jilin Province Huinan Changlong Bio-pharmacy Co was 38.30% per year. The lowest was -46.30% per year. And the median was 14.70% per year.

Competitive Comparison of Jilin Province Huinan Changlong Bio-pharmacy Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Jilin Province Huinan Changlong Bio-pharmacy Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jilin Province Huinan Changlong Bio-pharmacy Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jilin Province Huinan Changlong Bio-pharmacy Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Jilin Province Huinan Changlong Bio-pharmacy Co's 3-Year EBITDA Growth Rate falls into.

Jilin Province Huinan Changlong Bio-pharmacy Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Jilin Province Huinan Changlong Bio-pharmacy Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Jilin Province Huinan Changlong Bio-pharmacy Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jilin Province Huinan Changlong Bio-pharmacy Co Ltd (HKSE:08049) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

JIL:Germany

Address

625 & 639 Nathan Road, Room 1101-2, 11th Floor, Office Tower Two, Grand Plaza, Mong kok, Kowloon, Hong Kong, HKG

Website

http://www.jlchanglong.com

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd is a pharmaceutical company. It is engaged in the manufacturing and distribution of Chinese medicines and pharmaceutical products. The company sells medicines under the brand names: Changlong and Qing Tong. The group has only one business segment which is the manufacture and distribution of Chinese medicines. It derives revenue primarily from operations in the PRC.

Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049) Headlines

No Headlines